Firms

Duquesne Family Office
- Founded
- —
- Type
- Venture capital
Funds0
No funds on record yet.
Team
![]() Stanley Druckenmiller Duquesne Family Office, Chairman and Chief Executive Officer | $1M$100K – $5M | New York, New York |
Co-investing
Arbor Ventures
Lean Technologies$67M · 2024-11-11
Lean$67M · Unknown date
B Capital
Precision Neuroscience$250M · 2026-09-24
Precision Neuroscience$102M · 2024-12-16
Bain Capital Ventures
Lean Technologies$67M · 2024-11-11
Lean$67M · Unknown date
General Catalyst
Lean Technologies$67M · 2024-11-11
Lean$67M · Unknown date
Illumina Ventures
MyOme, Inc.$— · 2025-12-11
SonoThera$125M · Unknown date
Ackman Oxman Institute
Precision Neuroscience$250M · 2026-09-24
Alexandria Venture Investments
SonoThera$125M · Unknown date
ARCH Venture Partners
SonoThera$125M · Unknown date
ARK
Precision Neuroscience$250M · 2026-09-24
Bain Capital
Lean$67M · Unknown date
Casdin Capital
C2i Genomics$100M · 2021-04-15
General Equity Holdings
Precision Neuroscience$102M · 2024-12-16
Gobi Partners
C2i Genomics$100M · 2021-04-15
Hitachi Ventures
Precision Neuroscience$250M · 2026-09-24
JIMCO
Lean Technologies$67M · 2024-11-11
JIMCO Technology Fund
Lean Technologies$67M · 2024-11-11
JSL Health Capital
Precision Neuroscience$250M · 2026-09-24
Korea Investment Partners
Precision Neuroscience$250M · 2026-09-24
Leaps by Bayer
SonoThera$125M · Unknown date
Mirae Asset Capital
Precision Neuroscience$250M · 2026-09-24
Mubadala Capital
Precision Neuroscience$250M · 2026-09-24
NFX
C2i Genomics$100M · 2021-04-15
Pershing Square Capital Management
Precision Neuroscience$250M · 2026-09-24
S32
C2i Genomics$100M · 2021-04-15
Section 32
C2i Genomics$100M · 2021-04-15
Sequoia
MyOme, Inc.$— · 2025-12-11
Silver Lake
C2i Genomics$100M · 2021-04-15
Steadview Capital
Precision Neuroscience$102M · 2024-12-16
The Invus Group, LLC
Precision Neuroscience$250M · 2026-09-24
Vertex Ventures HC
SonoThera$125M · Unknown date
